Utilization of NKX3.1, P501S, Prostate-Specific Antigen, and Steroidogenic Factor 1 to Distinguish Malignant Leydig Cell Tumor From Metastatic Prostatic Adenocarcinoma to the Testis.
Erak E, Ulbright TM, Epstein J.
Arch Pathol Lab Med. 2023 Dec 1;147(12):1458-1460. doi: 10.5858/arpa.2022-0424-OA.
PMID:36881770
E2F4 Promotes Malignant Behaviors of Prostate Cancer Through Activating MUC1 Expression Transcriptionally.
Cheng L, Yang H, Tan S, Shi C, Zeng F, Yang W, Kong W.
Asia Pac J Clin Oncol. 2025 Oct;21(5):557-565. doi: 10.1111/ajco.14164. Epub 2025 Mar 20.